IL100581A0 - Boron compounds - Google Patents

Boron compounds

Info

Publication number
IL100581A0
IL100581A0 IL100581A IL10058192A IL100581A0 IL 100581 A0 IL100581 A0 IL 100581A0 IL 100581 A IL100581 A IL 100581A IL 10058192 A IL10058192 A IL 10058192A IL 100581 A0 IL100581 A0 IL 100581A0
Authority
IL
Israel
Prior art keywords
boron compounds
boron
compounds
Prior art date
Application number
IL100581A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919100995A external-priority patent/GB9100995D0/en
Priority claimed from GB919106877A external-priority patent/GB9106877D0/en
Priority claimed from GB919121733A external-priority patent/GB9121733D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of IL100581A0 publication Critical patent/IL100581A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22Tin compounds
    • C07F7/2284Compounds with one or more Sn-N linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL100581A 1991-01-17 1992-01-03 Boron compounds IL100581A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919100995A GB9100995D0 (en) 1991-01-17 1991-01-17 Boron compounds
GB919106877A GB9106877D0 (en) 1991-04-02 1991-04-02 Boron intermediates
GB919121733A GB9121733D0 (en) 1991-10-14 1991-10-14 Chemical compounds

Publications (1)

Publication Number Publication Date
IL100581A0 true IL100581A0 (en) 1992-09-06

Family

ID=27265454

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100581A IL100581A0 (en) 1991-01-17 1992-01-03 Boron compounds

Country Status (16)

Country Link
US (1) US5245035A (ja)
EP (1) EP0495627A1 (ja)
JP (1) JPH04312591A (ja)
KR (1) KR920014820A (ja)
AU (1) AU9011991A (ja)
CA (1) CA2058910A1 (ja)
CS (1) CS9892A3 (ja)
FI (1) FI920213A (ja)
GB (1) GB9200705D0 (ja)
HU (1) HU9200131D0 (ja)
IE (1) IE914573A1 (ja)
IL (1) IL100581A0 (ja)
MX (1) MX9200204A (ja)
NO (1) NO920223L (ja)
PT (1) PT100024A (ja)
ZW (1) ZW892A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403934A (en) * 1990-03-12 1995-04-04 Burroughs Wellcome Co. Heterocyclic compounds
WO1994020460A1 (en) * 1993-03-11 1994-09-15 Smithkline Beecham Corporation Chemical compounds
FR2711368B1 (fr) * 1993-09-16 1996-01-05 Roussel Uclaf Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus.
FR2712887B1 (fr) * 1993-11-26 1995-12-29 Synthelabo Dérivés de triarylborane, leur préparation et leur utilisation comme intermédiaires de synthèse.
WO2002097301A1 (en) 2001-05-29 2002-12-05 Braga Gomes Albuquerque Jose M Method of construction of multi-speed motor vehicle gearboxes
WO2002103340A2 (en) * 2001-06-20 2002-12-27 M.S. Tech Ltd Method and device for the detection of trace amounts of a substance,using a piezoelectric crystal element
US7041280B2 (en) 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6858592B2 (en) 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
UY30244A1 (es) 2006-03-30 2007-11-30 Tanabe Seiyaku Co Un proceso para preparar derivados de tetrahidroquinolina
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
US20220056052A1 (en) * 2018-12-28 2022-02-24 Riboscience Llc Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
HUT54991A (en) * 1989-08-11 1991-04-29 Ici Plc Process for producing quinoline derivatives and pharmaceutical compositions comprising such compounds
GB2244054B (en) * 1990-04-19 1994-04-06 Ici Plc Pyridine derivatives

Also Published As

Publication number Publication date
EP0495627A1 (en) 1992-07-22
ZW892A1 (en) 1992-09-30
US5245035A (en) 1993-09-14
CA2058910A1 (en) 1992-07-18
HU9200131D0 (en) 1992-04-28
AU9011991A (en) 1992-07-23
FI920213A0 (fi) 1992-01-17
CS9892A3 (en) 1992-08-12
IE914573A1 (en) 1992-07-29
JPH04312591A (ja) 1992-11-04
MX9200204A (es) 1992-10-01
NO920223L (no) 1992-07-20
NO920223D0 (no) 1992-01-16
GB9200705D0 (en) 1992-03-11
FI920213A (fi) 1992-07-18
KR920014820A (ko) 1992-08-25
PT100024A (pt) 1993-05-31

Similar Documents

Publication Publication Date Title
GB9102635D0 (en) Compounds
EP0511165A3 (en) Dicetopyrrolopyrrole compounds
ZW892A1 (en) Boron compounds
GB9107398D0 (en) Compounds
GB9113031D0 (en) Compounds
GB9101645D0 (en) Compounds
AP9200352A0 (en) Compounds
GB9114337D0 (en) Compounds
GB9104746D0 (en) Compounds
GB9104050D0 (en) Compounds
GB9100174D0 (en) Compounds
GB9102812D0 (en) Compounds
GB9100995D0 (en) Boron compounds
GB9107236D0 (en) Compounds
IL102679A0 (en) A87689 compounds
GB9107222D0 (en) Compounds
GB9107780D0 (en) Compounds
GB9106357D0 (en) Compounds
GB9100094D0 (en) Compounds
GB9101242D0 (en) Compounds
GB9101240D0 (en) Compounds
GB9101243D0 (en) Compounds
GB9102305D0 (en) Compounds
GB9102428D0 (en) Compounds
GB9103326D0 (en) Compounds